Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
MBX Biosciences, Inc. (MBX) had Operating Cash Flow per Share of $-2.19 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-86.97M |
|
-- |
|
-- |
|
$98.06M |
|
$-98.06M |
|
$11.08M |
|
$-86.97M |
|
$-86.97M |
|
$-86.97M |
|
$-86.97M |
|
$-86.97M |
|
$-86.97M |
|
$-98.06M |
|
$-97.81M |
|
36.51M |
|
36.51M |
|
$-2.38 |
|
$-2.38 |
|
| Balance Sheet Financials | |
$381.54M |
|
$2.73M |
|
$3.60M |
|
$385.14M |
|
$15.49M |
|
-- |
|
$0.43M |
|
$15.92M |
|
$369.22M |
|
$369.22M |
|
$369.22M |
|
44.93M |
|
| Cash Flow Statement Financials | |
$-79.95M |
|
$-83.70M |
|
$189.59M |
|
$49.35M |
|
$75.29M |
|
$25.94M |
|
$8.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
24.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-81.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.56% |
|
-23.56% |
|
-22.58% |
|
-23.56% |
|
$8.22 |
|
$-2.24 |
|
|
Operating Cash Flow per Share |
$-2.19 |